Matthew Coggin - 04 Mar 2022 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
SVP, Business Dev & Strategy
Signature
Dane Baumgardner, Attorney-In-Fact for Matthew Coggin
Issuer symbol
XRAY
Transactions as of
04 Mar 2022
Net transactions value
-$22,500
Form type
4
Filing time
08 Mar 2022, 15:20:23 UTC
Previous filing
19 Jan 2022
Next filing
14 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +3,283 +11% $0.000000 32,184 04 Mar 2022 Direct F1
transaction XRAY Common Stock Tax liability $8,096 -154 -0.48% $52.57 32,030 04 Mar 2022 Direct F2
transaction XRAY Common Stock Tax liability $14,404 -274 -0.86% $52.57 31,756 04 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Award $0 +1,400 $0.000000 1,400 04 Mar 2022 Common Stock 1,400 $53.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 4, 2025.
F2 Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units plus dividend equivalent rights, each as previously reported in Table I.
F3 Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2025.